Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05941858 · ClinicalTrials.gov registry record · NA

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

A NA study of Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05941858: Recruiting NA study of Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

NCT05941858 is a NA study of Cancer that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 200 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05941858, a NA study of Cancer, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates an online Tai Chi intervention to promote smoking cessation among cancer survivors. Tai chi is a practice that involves a series of slow gentle movements and physical postures, a meditative state of mind, and controlled breathing. It is a gentle form of exercise that can be done while sitting or standing and does not involve any medications or medical procedures. Tai chi originated as an ancient martial art in China. Over the years, it has become more focused on health promotion and rehabilitation. The use of Tai Chi may be beneficial for cancer patients who want to quit smoking.

Primary Outcome

Will be assessed by the participants in both groups by carbon monoxide (CO) verification and self-administered online surveys.

Conditions Studied

Interventions

  • OTHER Tai Chi
  • BEHAVIORAL Smoking Cessation Intervention
  • OTHER Survey Administration
  • OTHER Internet-Based Intervention
  • PROCEDURE Carbon Monoxide Measurement

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-11-11
Est. Completion 2025-12-31
Phase NA

What NCT05941858 shows while recruiting

NCT05941858 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Tai Chi is the first listed.

NCT05941858 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05941858 about?

NCT05941858 is a clinical study titled "Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors". This clinical trial evaluates an online Tai Chi intervention to promote smoking cessation among cancer survivors. Tai chi is a practice that involves a series of slow gentle movements and physical postures, a meditative state of mind, and controlled breathing. It is a gentle form of exercise that ca...

What is the current status of trial NCT05941858?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-11-11. Estimated completion is 2025-12-31.

What conditions does trial NCT05941858 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05941858?

The interventions under investigation include: Tai Chi (OTHER), Smoking Cessation Intervention (BEHAVIORAL), Survey Administration (OTHER), Internet-Based Intervention (OTHER), Carbon Monoxide Measurement (PROCEDURE).

Who is sponsoring clinical trial NCT05941858?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05941858 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05941858's enrollment target sits among peer trials

200 231st of 615 higher than 380 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05941858, the US trial registry maintained by the National Library of Medicine. NCT05941858 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.